HB 2696 – Oregon

Status: Inactive / Dead
Year Introduced: 2019
Link: https://legiscan.com/OR/bill/HB2696/2019

Establishes Drug Cost Review Commission to determine excess costs for certain prescription drugs and to set maximum payment rates for certain prescription drugs sold in this state by suppliers other than manufacturers. Requires investigation by Attorney General of complaints of payment rates that exceed payment rates established by commission. Adds new provisions considered unlawful trade practices.

Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found